Archives

The Food and Drug Administration issued a warning letter to a foreign manufacturer that the substation of methanol for ethanol rendered its produce a new drug, adulterated, and misbranded.

Center for Food Safety and Applied Nutrition sends FDA warning letter to CBD manufacturer of products for adults and kids – for adulteration/misbranding FD&C Act violations.

FDA issues warning letter to New York manufacturer for CBD claims that indicates its products are new drugs and do not qualify as dietary supplements

Cosmetics are regulated by the Food, Drug, and Cosmetic Act. FDA’s primary focus on whether the cosmetics have been adulterated or misbranded.

Healthcare makers, distributors, and sellers must comply with FDA rules and warning letters for their cannabis, hemp, and THC products including foods, OTC drugs, cosmetics, and dietary supplements

Healthcare makers, distributors, and sellers must comply with FDA rules and warning letters for their cannabis, hemp, and THC products including foods, OTC drugs, cosmetics, and dietary supplements

FDA sends warning letter to a company because its website and social media accounts made claims about CBD products that suggest they are drugs or dietary supplements and were misbranded.

The FDA examines whether medical devices comply with the regulations of the Food, Drug, and Cosmetic Act. Two of the most common violations medical device companies are charged are adulteration [...]

FDA and FTC warning letters continue to find violations of the FD&C Act when companies boast their products can cure or treat diseases such as COVID-19.

The FDA issues warning letters for numerous products including dietary supplements. FDA violations include findings that the supplement is a new drug, product adulteration, misbranding, and [...]